Elevance Health, Inc. (ELV)
Elevance raises annual profit forecast betting on cost control
Elevance Health raised its annual profit forecast on Wednesday, as it looks to keep medical costs in check.
Stay Ahead of the Game With Elevance Health (ELV) Q1 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for Elevance Health (ELV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
Will Health Benefits Weakness Drag Elevance's Q1 Earnings?
ELV heads into its April 22 Q1 report with EPS likely down 11.4% as Health Benefits operating income is projected to plunge 13.7% year over year.
Elevance Health: New Medicare Payment Rate A Gift, And The Chart Looks Good
Elevance Health, Inc. is rated a Buy, with valuation now compelling after significant underperformance versus the S&P 500. Despite fundamental headwinds—declining membership, higher benefit expense ratios, and muted guidance—ELV targets 12% annual adjusted EPS growth long-term. Shares are deeply discounted, trading below fair value on both P/E and price-to-sales metrics, with technicals suggesting a potential bottom.
Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report?
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
California Public Employees Retirement System Raises Stock Position in Elevance Health, Inc. $ELV
California Public Employees Retirement System lifted its position in shares of Elevance Health, Inc. (NYSE: ELV) by 3.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 558,136 shares of the company's stock after acquiring an additional 19,153 shares during the
Elevance Health, Inc. $ELV Shares Sold by Alliancebernstein L.P.
Alliancebernstein L.P. trimmed its holdings in Elevance Health, Inc. (NYSE: ELV) by 34.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 913,051 shares of the company's stock after selling 482,748 shares during the period. Alliancebernstein L.P. owned about
Is the Options Market Predicting a Spike in Elevance Health Stock?
Investors need to pay close attention to ELV stock based on the movements in the options market lately.
Health Insurance Stock Could Rebound Off Historically Bullish Signal
Elevance Health Inc (NYSE:ELV) stock yesterday enjoyed its biggest single-day percentage gain since May 2024 after reporting $547 million in profits, but it wasn't enough to erase its worst day since March 2020 in the previous session, after the Centers for Medicare & Medicaid Services proposed to raise Medicare Advantage payment rates by only 0.09% in 2027.
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums
ELV tops Q4 EPS estimates as premiums grow and Carelon revenues surge, even as medical membership slips and expenses climb.
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
